BioLineRx (BLRX) Tops Q1 EPS by 16c
Tweet
Share
E-mailBioLineRx (NASDAQ: BLRX) reported Q1 EPS of $0.00, $0.16 better than the analyst estimate of ($0.16). Revenue for the quarter came in at $6.85 million versus the consensus estimate of $1.82 million.
For earnings history and earnings-related data on BioLineRx (BLRX) click here.
Create E-mail Alert Related Categories
EarningsRelated Entities
EarningsSign up for StreetInsider Free!
Receive full access to all new and archived articles, unlimited portfolio tracking, e-mail alerts, custom newswires and RSS feeds - and more!
